Helicobacter pylori plays an important role in the pathogenesis of chronic active gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lym- phoma, and is also involved in carcinogenesis of the stomach. Since now no current first-line therapy is able to cure the infection in all treated patients. We evaluated data on the most successful therapy regi- mens—sequential, concomitant and quadruple thera- pies—and on the standard therapy available for H. pylori eradication. When therapy fails several factors may be involved: we reviewed both bacterial and host factors that can affect the eradication and that can be involved in therapeutic management of the H. pylori infection.
Therapy for H. pylori: Current concepts
RICCI, Chiara;
2013-01-01
Abstract
Helicobacter pylori plays an important role in the pathogenesis of chronic active gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lym- phoma, and is also involved in carcinogenesis of the stomach. Since now no current first-line therapy is able to cure the infection in all treated patients. We evaluated data on the most successful therapy regi- mens—sequential, concomitant and quadruple thera- pies—and on the standard therapy available for H. pylori eradication. When therapy fails several factors may be involved: we reviewed both bacterial and host factors that can affect the eradication and that can be involved in therapeutic management of the H. pylori infection.File | Dimensione | Formato | |
---|---|---|---|
OJGas_2013 Fiorini.pdf
gestori archivio
Tipologia:
Altro materiale allegato
Licenza:
PUBBLICO - Pubblico senza Copyright
Dimensione
47.98 kB
Formato
Adobe PDF
|
47.98 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.